The use of herpes simplex virus-based vectors for gene delivery to the nervous system

This publication has 30 references indexed in Scilit:

• Construction and Characterization of Herpes Simplex Virus Type 1 Mutants with Conditional Defects in Immediate Early Gene Expression
  Virology, 1997
• A Genetically Inactivated Herpes Simplex Virus Type 2 (HSV-2) Vaccine Provides Effective Protection against Primary and Recurrent HSV-2 Disease
  The Journal of Infectious Diseases, 1997
• In vivo complementation studies of a glycoprotein H-deleted herpes simplex virus-based vector
  Journal of General Virology, 1996
• Herpes simplex virus vector system: analysis of its in vivo and in vitro cytopathic effects
  Journal of Neuroscience Methods, 1995
• Neurons containing latency-associated transcripts are numerous and widespread in dorsal root ganglia following footpad inoculation of mice with herpes simplex virus type 1 mutant in1814
  Journal of General Virology, 1993
• Herpes simplex virus latent phase transcription facilitates in vivo reactivation
  Virology, 1990
• Construction and characterization of a herpes simplex virus type 1 mutant unable to transinduce immediate-early gene expression
  Journal of Virology, 1989
• An Inquiry into the Mechanisms of Herpes Simplex Virus Latency
  Annual Review of Microbiology, 1987
• RNA Complementary to a Herpesvirus α Gene mRNA Is Prominent in Latently Infected Neurons
  Science, 1987
• Analysis of DNA sequences which regulate the transcription of herpes simplex virus immediate early gene 3: DNA sequences required for enhancer-like activity and response to trans-activation by a virion polypeptide
  Nucleic Acids Research, 1986